EZH2 and major depressive disorder: To elaborately verify the role of miR-29b-3p in depression, miR-29b-3p inhibitor was transfected into the sh-EZH2-treated cells to reduce intracellular miR-29b-3p expression, and it was unveiled that both inflammatory response and microglia polarization into M1 type were enhanced.